v3.22.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenue $ 1,953 $ 125
Costs and expenses:    
Cost of revenue (excluding depreciation and amortization) 568 181
Research and development 7,338 3,654
Sales and marketing 1,871 227
General and administrative 9,194 2,956
Depreciation and amortization 1,266 445
Total operating costs and expenses 20,237 7,463
Loss from operations (18,284) (7,338)
Change in fair value of warrant liabilities 13,448 0
Other income (expense), net 609 3
Loss before benefit for income taxes (4,227) (7,335)
Benefit for income taxes 0 0
Net loss $ (4,227) $ (7,335)
Net loss per share attributable to common stockholders - basic and diluted $ (0.02) $ (0.06)
Weighted average shares used in computing net loss per share attributable to common stockholders – basic and diluted 196,183,247 118,718,574